These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6366503)

  • 1. Autologous bone marrow transplantation in the treatment of children and adolescents with advanced malignant tumors.
    Baumgartner C; Bleher EA; Brun del Re G; Bucher U; Deubelbeiss KA; Greiner R; Hirt A; Imbach P; Lüthy A; Odavic R
    Med Pediatr Oncol; 1984; 12(2):104-11. PubMed ID: 6366503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with high dose multiagent chemotherapy and autologous bone marrow rescue in the treatment of twenty-two children with advanced tumours.
    Ekert H; Tiedemann K; Waters KD; Ellis WM
    Aust Paediatr J; 1984 Aug; 20(3):195-201. PubMed ID: 6391455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
    McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
    J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autologous bone marrow transplantation in pediatric cancer].
    Ohira M
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2299-306. PubMed ID: 2260867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
    Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
    J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation in paediatric solid tumours.
    Pinkerton R; Philip T; Bouffet E; Lashford L; Kemshead J
    Clin Haematol; 1986 Feb; 15(1):187-203. PubMed ID: 3516489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
    Verdonck LF; Dekker AW; de Gast GC; van Kempen ML; Lokhorst HM; Nieuwenhuis HK
    J Clin Oncol; 1992 Dec; 10(12):1949-54. PubMed ID: 1453209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study].
    Wu GQ
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):47-51. PubMed ID: 7687533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma.
    Horowitz ME; Kinsella TJ; Wexler LH; Belasco J; Triche T; Tsokos M; Steinberg SM; McClure L; Longo DL; Steis RG
    J Clin Oncol; 1993 Oct; 11(10):1911-8. PubMed ID: 8410118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
    Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM
    J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
    Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
    J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
    Kushner BH; Gulati SC; Kwon JH; O'Reilly RJ; Exelby PR; Cheung NK
    Cancer; 1991 Jul; 68(2):242-7. PubMed ID: 1906368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemopoietic reconstitution after repeated autologous transplantation with mafosfamide-purged marrow.
    Beaujean F; Hartmann O; Benhamou E; Lemerle J; Duedari N
    Bone Marrow Transplant; 1989 Sep; 4(5):537-41. PubMed ID: 2790332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.
    Freedman AS; Takvorian T; Neuberg D; Mauch P; Rabinowe SN; Anderson KC; Soiffer RJ; Spector N; Grossbard M; Robertson MJ
    J Clin Oncol; 1993 May; 11(5):931-6. PubMed ID: 8487057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
    Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
    Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation.
    Seeger RC; Reynolds CP
    Pediatr Clin North Am; 1991 Apr; 38(2):393-424. PubMed ID: 2006084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma.
    Boulad F; Kernan NA; LaQuaglia MP; Heller G; Lindsley KL; Rosenfield NS; Abramson SJ; Gerald WL; Small TN; Gillio AP; Gulati SC; O'Reilly RJ; Ghavimi F
    J Clin Oncol; 1998 May; 16(5):1697-706. PubMed ID: 9586881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease.
    Yahalom J; Gulati S; Shank B; Clarkson B; Fuks Z
    Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):915-22. PubMed ID: 2478511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.
    Williams CD; Pearce R; Taghipour G; Green ES; Philip T; Goldstone AH
    J Clin Oncol; 1994 Nov; 12(11):2415-22. PubMed ID: 7964958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive cytoreductive therapy followed by autologous bone marrow transplantation for patients with hematologic malignancies or solid tumors.
    Verdonck LF; Dekker AW; Vendrik PJ; van Kempen ML; Schornagel JH; Rozenberg-Arska M; de Gast GC
    Cancer; 1987 Aug; 60(3):289-95. PubMed ID: 3297283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.